Login / Signup

SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.

Yuelong YanHongqi TengQinglei HangLavanya KondiparthiGuang LeiAmber D HorbathXiaoguang LiuChao MaoShiqi WuLi ZhuangM James YouMasha V PoyurovskyLi MaKellen OlszewskiBoyi Gan
Published in: Nature communications (2023)
The cystine transporter solute carrier family 7 member 11 (SLC7A11; also called xCT) protects cancer cells from oxidative stress and is overexpressed in many cancers. Here we report a surprising finding that, whereas moderate overexpression of SLC7A11 is beneficial for cancer cells treated with H 2 O 2 , a common oxidative stress inducer, its high overexpression dramatically increases H 2 O 2 -induced cell death. Mechanistically, high cystine uptake in cancer cells with high overexpression of SLC7A11 in combination with H 2 O 2 treatment results in toxic buildup of intracellular cystine and other disulfide molecules, NADPH depletion, redox system collapse, and rapid cell death (likely disulfidptosis). We further show that high overexpression of SLC7A11 promotes tumor growth but suppresses tumor metastasis, likely because metastasizing cancer cells with high expression of SLC7A11 are particularly susceptible to oxidative stress. Our findings reveal that SLC7A11 expression level dictates cancer cells' sensitivity to oxidative stress and suggests a context-dependent role for SLC7A11 in tumor biology.
Keyphrases